Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Cue Health stock
Learn how to easily invest in Cue Health stock.
Cue Health, maker of COVID-19 tests, completed its initial public offering at $16 per share, right in the middle of its pricing expectations. The IPO raised $200 million for the company and gives it a valuation of $2.3 billion.
HLTH will debut on the Nasdaq later today, but shares are available for limit orders on Robinhood and other platforms.
How to buy shares in Cue Health
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HLTH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cue Health stock price (NASDAQ: HLTH)Use our graph to track the performance of HLTH stocks over time.
Cue Health shares at a glance
|Latest market close||$2.93|
|52-week range||$2.75 - $22.55|
|50-day moving average||$3.65|
|200-day moving average||$6.70|
|Wall St. target price||$8.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.21|
Buy Cue Health shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cue Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cue Health price performance over time
|1 week (2022-09-20)||-10.40%|
|1 month (2022-08-26)||-17.23%|
|3 months (2022-06-28)||-14.33%|
|6 months (2022-03-28)||-56.53%|
|1 year (2021-09-28)||-80.70%|
|2 years (2020-09-24)||N/A|
|3 years (2019-09-24)||N/A|
|5 years (2017-09-24)||N/A|
Is Cue Health stock undervalued or overvalued?
Valuing Cue Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cue Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cue Health's P/E ratio
Cue Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Cue Health shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Cue Health's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.
Cue Health's EBITDA
Cue Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $50.9 million.
The EBITDA is a measure of a Cue Health's overall financial performance and is widely used to measure a its profitability.
To put Cue Health's EBITDA into context you can compare it against that of similar companies.
Cue Health financials
|Revenue TTM||$683.3 million|
|Operating margin TTM||1.91%|
|Gross profit TTM||$298.7 million|
|Return on assets TTM||1.05%|
|Return on equity TTM||-11.3%|
|Market capitalisation||$484.5 million|
TTM: trailing 12 months
Cue Health share dividends
We're not expecting Cue Health to pay a dividend over the next 12 months.
You may also wish to consider:
- Quest Diagnostics Incorporated (DGX.US) (2.16% forward annual dividend yield)
Cue Health overview
Cue Health Inc. , a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Frequently asked questionsWhat percentage of Cue Health is owned by insiders or institutions?
Currently 15.238% of Cue Health shares are held by insiders and 48.664% by institutions. How many people work for Cue Health?
Latest data suggests 1,585 work at Cue Health. When does the fiscal year end for Cue Health?
Cue Health's fiscal year ends in December. Where is Cue Health based?
Cue Health's address is: 4980 Carroll Canyon Road, San Diego, CA, United States, 92121 What is Cue Health's ISIN number?
Cue Health's international securities identification number is: US2297901009
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert